ADR120S

ADR120S FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of ADR120S (3750.T) as of Nov 3, 2026 is 197.72 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 46.50 % — a change of 325.22% (higher).

FCF Conversion

197.72 %

YoY

325.22%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of ADR120S is 2026 197.72 % . FCF Conversion Rate (FCF/EBITDA) of ADR120S was 2025 46.50 % . It decreases by 325.22% higher compared to the previous year.

The ADR120S FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2019
-466.62 JPY
Jan 1, 2020
161.75 JPY
Jan 1, 2021
11.88 JPY
Jan 1, 2022
473.81 JPY
Jan 1, 2023
18.68 JPY
Jan 1, 2024
-845.77 JPY
Jan 1, 2025
46.50 JPY
Jan 1, 2026
197.72 JPY
The ADR120S FCF Conversion history
YEARFCF ConversionYoY
197.72 %+325.22%
46.50 %-105.50%
-845.77 %-4,626.75%
18.68 %-96.06%
473.81 %+3,887.07%
11.88 %-92.65%
161.75 %-134.66%
-466.62 %-976.88%
53.21 %-114.04%
-378.97 %-68.77%
-1,213.39 %+21,375.64%
-5.65 %-97.84%
-261.80 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ADR120S Stock analysis

What does ADR120S do? ADR120S Inc generates revenue through its Real Asset segment, which involves buying and selling real estate, developing and operating hotels, and investing in real estate projects. The Medical segment focuses on regenerative medicine, selling medical equipment like the Celusion centrifuge and Celusion cell therapy kit, and providing cell therapy services. The company serves clients in real estate development, hotel operations, and healthcare sectors, with products targeting medical facilities and clinics specializing in regenerative treatments. The Real Asset segment handles property transactions, hotel management, and real estate investments, while the Medical segment offers cell therapy solutions through its branded products. Both segments target businesses seeking to expand in real estate or adopt advanced medical technologies, with the Celusion products being key revenue drivers in the healthcare market. ADR120S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ADR120S stock

FCF Conversion Rate (FCF/EBITDA) of ADR120S is 197.72 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of ADR120S changed from 46.50 % to 197.72 %, representing a 325.22% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) ADR120S since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s ADR120S with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — ADR120S

All Key Metrics — ADR120S